Support for the Michigan Oncology Quality Consortium is provided by Blue Cross and Blue Shield of Michigan (BCBSM) as part of the BCBSM Value Partnerships program. BCBSM’s Value Partnerships program provides clinical and executive support for all CQI programs. Although Blue Cross Blue Shield of Michigan and MOQC work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.
Clinician Report of Oral Oncolytic Symptoms and Adherence Obtained via a Patient-Reported Outcome Measure (PROM)
/in News /by wagdesignView on Journal of Oncology Practice, May 17, 2019 Download the PDF
Clinician Perspectives on Electronic Health Records, Communication, and Patient Safety Across Diverse Medical Oncology Practices
/in News /by wagdesignQuestion: How do electronic health records (EHRs), satisfaction with technology, and clinician communication enable a safety culture in ambulatory oncology treatment settings?
New Persistent Opiod Use Among Patients with Cancer After Curative-Intent Surgery
/in News /by wagdesignJournal of Clinical Oncology, December 20, 2017
Cancer Health Disparities Due to Sexual Orientation and Gender Identity
/in News, Uncategorized /by wagdesignMOQC Physician Quoted
/in News /by moqc@moqcDr. Tallat Mahmood was interviewed for an article in Cure Magazine that highlights her practice’s work on improving adherence in patients taking oral chemotherapy…
How Culture Can Impact Clinical Care
/in News /by moqc@moqcDr. Tallat Mahmood shares her story